Objectives: Alzheimer's disease (AD) and the behavioral variant of frontotemporal dementia (bvFTD) are the most common causes of dementia; however, their overlapping clinical syndromes and involved brain regions make a differential diagnosis difficult. We aimed to identify the differences in the cognition and motor cortex excitability between AD and bvFTD patients. Methods: Twenty-seven AD patients and 30 bvFTD patients were included in the study. Each participant received a neurological evaluation. Cognitive event-related potentials (P300) were recorded during an auditory oddball task. Next, the excitability of the motor cortex, including the resting, facilitated motor threshold (RMT and FMT) and cortical silent period (CSP), were assessed during transcranial magnetic stimulation (TMS). Results: The bvFTD patients exhibited significantly longer P300 latencies compared with AD patients. There was a significant negative correlation between cognition and P300 latency in the bvFTD group. The AD patients showed significantly reduced RMT and FMT values compared to the bvFTD group; however, no significant correlation was found between AD severity and the excitability of the motor cortex. Conclusions: Cognition and motor cortical functions are different between AD and bvFTD patients. Noninvasive electrophysiological examinations have the potential to identify unique pathophysiological features that can be used to differentially diagnose AD and bvFTD patients. 
Introduction
With medical advances, mortality rates among older people are decreasing, and the average life expectancy is increasing worldwide. As people live longer, chronic diseases become more prevalent, and dementia is one of the most common chronic diseases in older people. According to the World Alzheimer Report of 2015, there are over 46 million people with dementia worldwide [1] . Alzheimer's disease (AD) and frontotemporal dementia (FTD) are the most common primary causes of dementia syndrome [1] [2] [3] . These two diseases are characterized by distinct clinical syndromes and the involved brain regions. However, these characteristics begin to overlap as the diseases progress. Clinically, episodic memory loss is typically the primary clinical symptom of AD. Changes in language, orientation, mood, motivation and behavior are also frequent, particularly as the disease progresses [4] . The behavioral variant of FTD (bvFTD) is the most common subtype of FTD and is characterized by marked personality changes and behavioral problems, as well as cognitive changes that affect executive function and episodic memory [5] . A recent longitudinal AD study reported that structural changes occur early in the bilateral parietal, hippocampal and association occipital regions; furthermore, these regions continue to atrophy over time, and temporal lobe changes are observed in later stages [6] . Conversely, bvFTD patients show early degradation of the medial prefrontal cortex followed by changes in the anterior temporal and frontal cortices [6] . Owing to the overlap in clinical symptoms and affected regions between bvFTD and AD [7] [8] [9] , an early differential diagnosis can be challenging. To improve diagnostic accuracy and early differential diagnoses, there is a strong need for markers of the unique brain changes associated with each type of dementia.
Cognitive deficits are typically the first symptoms of dementia to be recognized and a common reason for patients to go to the hospital. The P300 wave is a prominent eventrelated potential (ERP) that indicates changes in the association cortex [10] , working memory and attention functioning [11, 12] . The P300 wave is the most commonly recorded potential and can be elicited using the oddball paradigm.
In this method, the subject is instructed to only attend to an infrequent target stimulus embedded in a series of frequent background stimuli [13] . Many studies reported that AD patients showed diminished P300 amplitudes and enlarged P300 latencies when compared with age-matched controls [14] [15] [16] [17] [18] .
Furthermore, some studies have suggested P300 as a biomarker to distinguish between AD patients and age-matched controls [17, [19] [20] [21] . Few studies have analyzed the P300 component in FTD patients as compared to age-related controls or AD patients, and the results were not consistent enough to draw a conclusion. Jimenez-Escrig and colleagues found that the P300 wave did not significantly differ between FTD patients and age-matched controls; however, AD patients showed a delayed P300 latency that significantly differed from FTD patients [22] . Another study found that bvFTD patients displayed a longer P300 latency and smaller amplitude than the control group; however, no difference was found between the AD and bvFTD groups [23] . These contrasting P300 results between AD and FTD patients prompted us to investigate if bvFTD patients present abnormalities in P300 that can be used as a diagnostic tool to differentiate between bvFTD and AD patients.
In addition to the progressive deterioration of memory and cognitive functions, motor manifestations, such as bilateral spasticity in the lower limbs, myoclonus, gait disturbances and the presence of an extensor plantar response, are frequently observed in the advanced phases of AD and FTD [24] [25] [26] .
Transcranial magnetic stimulation (TMS) is a safe, noninvasive and painless technique that is widely employed to explore brain motor functions [27, 28] . Many TMS studies have demonstrated a hyperexcitability in the motor cortex that relates to AD severity [29] [30] [31] [32] . In contrast, there are few TMS studies on FTD patients. Alberici et al. suggested that TMS may help distinguish differences across the FTD clinical spectrum [33] . However, Pierantozzi et al. suggested that the motor cortex is not involved in FTD [34] . These inconsistent findings require further verification.
We hypothesized that there are differences in the cognition and motor cortex excitability between AD and bvFTD patients that explain the different behavioral and cognitive features of each type of dementia. Therefore, 
Experimental procedures
Standard protocol approvals, registration, and patient consent Rating (CDR) scales. The MMSE is a brief measure of cognitive functioning, and it has high testretest reliability, internal consistency and interobserver reliability [39] . The MMSE consists of 11 items and has a maximum score of 30 and a cut-off score of 24 with a sensitivity of 87% and specificity of 82% [40] . The MoCA is a 30-point cognitive test consisting of executive function and attention tasks that were designed for individuals who scored 24-30 on the MMSE [41, 42] . Thus, we used the MMSE and MoCA as measures of general cognition. The CDR offers a global characterization of everyday functions that may be affected by the neurodegenerative disease and is a clinical scale developed to assess the presence and severity of dementia [43] . The CDR is a five-point scale in which CDR-0 denotes no cognitive impairment. The remaining four points represent various stages of dementia (0.5 = mild cognitive impairment, 1 = mild dementia, 2 = moderate dementia, 3 = severe dementia). In our study, all of the patients with dementia scored 1-2 on the CDR.
In other words, we chose participants with mild-to moderate cognitive impairment. Due to the limited sample size, we did not create subgroups for disease severity.
A total of 80 subjects with cognitive impairment were enrolled in the study. Sixtyfive subjects met the criteria for AD or bvFTD, and 15 subjects had other types of dementia.
Eight subjects did not complete the ERP experiments. Thus, 27 AD patients and 30 bvFTD patients were included in the final analysis.
The demographic and neuropsychological details of the participants are listed in Tables 1   and 2 . The participants first underwent the ERP examination, and then completed the TMS examination 30 min later.
ERP procedure
The auditory oddball stimuli used were simple and easily gained the attention of the subjects. The oddball P300 is an indicator of memory function, and many studies have investigated the utility of auditory P300
for the assessment of AD [44] [45] [46] . A simple auditory two-tone discrimination (oddball paradigm) was used to elicit ERP responses. using simple recording channels [13] . In support of a previous study [47] , these authors also suggested that analyzing ERPs collected at the C z and P z provides a good initial view of cognitive processes. Based on the involved regions in dementia, we limited our study to ERPs at the P z and C Z . Two linked electrodes were attached to the left and right earlobes (A1-A2) as a reference. Other electrodes were placed above and below the left eye to monitor eye movements, and one ground electrode was attached to the middle of the forehead.
Subjects were comfortably seated in an armchair in a sound-attenuated room and asked to relax, close their eyes, and minimize eye and mandibular movements during the recording. Subjects were requested to press a hand-held button when they detected a target stimulus. They were also requested to silently count the target tones, and report the total number of tones at the end of the session.
The test was initiated only when the subject demonstrated a complete understanding of the task. All datasets with a 95% concordance between the number of stimuli presented and the total number of tones reported were used for further analysis.
The data were initially band-pass filtered between 0.2 and 20 Hz. The recording was initiated at 100 ms before stimulation to capture a baseline measurement. The recording was maintained for 900 ms thereafter. Next, eye movement components were removed using an algorithm [48] . After their removal, the remaining components were back-projected onto the EEG channels. The P300 amplitude was defined relative to the baseline period, which was set at the 100 ms level prior to stimulus onset. An automated peak-picking procedure was used to determine peak amplitudes and latencies. The P300 wave was defined as the maximum point between 300 and 600 ms after stimulus onset. Reaction times were not recorded for the oddball paradigm.
TMS procedure All participants were tested while lying comfortably in order to achieve complete relaxation. The EMG was monitored in the background using acoustic feedback before and during all TMS recordings. 
Results

Subject characteristics
The AD and bvFTD groups did not statistically differ in age (t = 1.83, p = 0.073), the number Table 1 .
Cognitive cortical cunction
All subjects responded to the target tones of the auditory ERPs with greater than 95% accuracy.
Among the ERP parameters measured in this study, the P300 latency in the bvFTD group was significantly longer than in the AD group at the P Z site (AD: 377.44 ± 7.35, bvFTD: 400.97 ± 6.33, t = -2.439, p = 0.018) and C Z site (AD: 378.63 ± 7.65, bvFTD: 398.90 ± 6.33, t = -2.057, p = 0.044).
The AD group did not significantly differ from the bvFTD group in P300 amplitude at either site (P Z : t = 0.385, p = 0.701 and C Z : t = 1.102, p = 0.313). The data are shown in Table 3 and Fig. 1 . Furthermore, we correlated the ERP parameters with the cognition scores (Supplementary Table 2 AD, Alzheimer's disease; bvFTD, the behavioral variant of frontotemporal dementia; C z , central; P z , parietal; *P, significant group differences (P < 0.05). 
Motor cortical function
There were no significant differences between the right and left hemispheres in any of the motor cortical excitability parameters (Table 4 and Fig. 4) . Thus, the average of both hemispheres was used for the AD and bvFTD amplitude of the P300 is considered to be the manifestation of brain activity that reflects attention to incoming stimulus information [12] . Previous studies have shown decreased P300 amplitudes and increased P300 latencies in AD patients [3, 18, 23, 49, 50] . In recent years, the utility of P300 in bvFTD patients has been studied. Chen and colleagues found decreased P300 amplitudes and increased P300 latencies in FTD patients when compared with agematched controls [23] . The abnormal P300 components may be due to changes in the brain regions associated with the P300. P300
generation involves a widespread network of cortical structures that overlap in AD and FTD, including parietal, temporal, and prefrontal cortices [51, 52] .
Furthermore, recent studies analyzed the P300 component in FTD and AD patients.
Jimenez-Escrig and colleagues found that the P300 latency of FTD patients was significantly longer compared with the AD group [22] . However, another study showed no difference between AD and bvFTD patients [23] . Interestingly, our study found that bvFTD patients had a longer P300 latency compared with AD patients. One reason for this discrepancy may be due to subject selection.
FTD is rather heterogeneous clinical entity and shows variable clinical and neuropathological manifestations. We assessed only bvFTD patients. In contrast, patients with primary progressive aphasia and semantic dementia were included in the study by Jimenez-Escrig.
The specific molecular pathologies and involved brain regions of different dementia subtypes may affect ERP parameters to some extent.
Another explanation is that clinically diagnosed Our study identified increased excitability of the motor cortex in AD patients when compared with bvFTD patients. These findings are consistent with previous studies [29, [53] [54] [55] [56] .
Recent neuropathological studies showed that the density of neurofibrillary tangles and senile plaques in the motor cortex was approximately equivalent to other areas considered to be specific targets for AD abnormalities [57, 58] . Secondly, the primary motor cortex expresses muscarinic receptors and receives widespread inputs from cholinergic pathways.
Therefore, some researchers have suggested that the cholinergic deficits in AD modify the excitability and function of the motor system [59] [60] [61] . Clinically, the excitability changes occur long before clinical signs of motor deficits are detected [62] . We speculate that the observed hyperexcitability is a compensatory mechanism to execute voluntary movements.
In contrast, the excitability of the motor cortex was preserved in the bvFTD group. Thus, TMS has the potential to be used as a noninvasive tool for reaching an early differential diagnosis between cholinergic (AD) and non-cholinergic forms of dementia (FTD). FTD includes a wide spectrum of heterogeneous clinical and anatomical conditions. Alberici and colleagues found that TMS might help in distinguishing differences among the FTD clinical spectrum [33] .
Furthermore, we found a lack of correlation between AD severity and cortical excitability parameters. These findings are consistent with the study by Ferreri et al. [54] . In contrast,
Alagona et al. [63] found a significant correlation between RMT and MMSE, indicating that the lower the MMSE score, the lower the RMT 
Conclusions
The novel findings of the present study concern the differences in cortical functioning between patients with AD and bvFTD. The 
